Frontlight ResearchEarly access
CompletedNo phase
Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)
Key facts
- Who runs it
- AcuFocus, Inc.
- Where
- Bakersfield, Bloomington, Brecksville, Draper, Fort Collins, Greensboro, Houston, Laguna Hills, Los Altos, Los Angeles, Norfolk, Ogden, Omaha, Philadelphia, Poughkeepsie, San Antonio, Sioux Falls, St Louis, Tucson, and Wilkes-Barre, United StatesSee the 20 sites
- Trial code
- Status
- Completed
- People taking part
- 196 people enrolled
- Started
- 12 Jan 2023
- Ended
- 16 Feb 2024
- Type of study
- Observational
- Record updated
- 2 April 2024
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Enrolled in Investigational Device Exemption (IDE) G180075 study and implanted with the IC-8 Apthera intraocular lens (IOL)
- Able to comprehend and have signed a statement of informed consent
- Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)
Who cannot take part
- There are no exclusion criteria for this study
Where in United States
- Empire Eye & Laser CenterBakersfield, United States
- Chu Vision InstituteBloomington, United States
- Cleveland Eye ClinicBrecksville, United States
- Hoopes VisionDraper, United States
- Eye Center of Northern ColoradoFort Collins, United States
- Physicians ProtocolGreensboro, United States
- Baylor College of MedicineHouston, United States
- Harvard Eye AssociatesLaguna Hills, United States
- Altos Eye PhysiciansLos Altos, United States
- Advanced Vision CareLos Angeles, United States
- Virginia Eye ConsultantsNorfolk, United States
- Utah Eye CentersOgden, United States
- Kugler VisionOmaha, United States
- Philadelphia Eye AssociatesPhiladelphia, United States
- Alterman, Modi & WolterPoughkeepsie, United States
- Parkhurst NuVisionSan Antonio, United States
- Vance Thompson VisionSioux Falls, United States
- Pepose Vision InstituteSt Louis, United States
- Fishkind, Bakewell, Maltzman, Hunter & Associates Eye Care & Surgery CenterTucson, United States
- Bucci Laser VisionWilkes-Barre, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the long-term safety of the IC-8 Apthera intraocular lens (IOL).
The group in the trial
- IC-8 Apthera intraocular lens (IOL) Group
Patients previously enrolled in the IC-8 Apthera IOL Investigational Device Exemption (IDE) study (G180075) and implanted with the IC-8 Apthera IOL.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-approval Follow-up Study of the IC-8 Apthera IOL
- Record updated
- 2 April 2024